MONOD BIO
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and amplification to detect a range of target molecules. It utilizes recent advances in computational protein engineering to create highly modular bio-sensing nano switches that stimulate rapid, sensitive, and inexpensive analytical assays. Monod Bio was founded in 2021 and is headquartered in Seattle, Washington.
MONOD BIO
Social Links:
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2021-11-01
Address:
Seattle, Washington, United States
Country:
United States
Website Url:
http://www.monod.bio
Total Employee:
1+
Status:
Active
Contact:
+1 206 822 1255
Total Funding:
25 M USD
Similar Organizations
Akarna Therapeutics
At Akarna, our mission is to develop best-in-class treatments for NASH and other chronic liver diseases
BionPharma
BionPharma develops and commercializes affordable quality generics and builds strong and effective partnerships.
Dilyx Biotechnologies
Dilyx Biotechnologies offers protein solubility analysis kits.
Henry Ford Health System
Henry Ford Health System (HFHS) is one of the nation’s leading comprehensive, integrated health systems.
Current Employees Featured
Founder
Investors List
Global Health Investment Fund (GHIF)
Global Health Investment Fund (GHIF) investment in Seed Round - Monod Bio
Matrix Capital Management
Matrix Capital Management investment in Seed Round - Monod Bio
Boom Capital
Boom Capital investment in Seed Round - Monod Bio
Washington Research Foundation
Washington Research Foundation investment in Seed Round - Monod Bio
Sahsen Ventures
Sahsen Ventures investment in Seed Round - Monod Bio
Cercano Management
Cercano Management investment in Seed Round - Monod Bio
Pack Ventures
Pack Ventures investment in Seed Round - Monod Bio
Official Site Inspections
http://www.monod.bio
- Host name: 23.185.0.4
- IP address: 23.185.0.4
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Monod Bio"
Monod Bio - AI-Powered Protein Design
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a …See details»
Our Team - Monod Bio
We launched Monod Bio in 2022 as a spin-out from the Baker Lab at the University of Washington (UW) Institute for Protein Design (IPD). Since then, ... He is a co-founder and VP at Neoleukin …See details»
Monod Bio - Crunchbase Company Profile & Funding
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Its biosensor platform combines binding, transduction, and …See details»
Monod Bio - LinkedIn
Monod Bio, a company co-founded by 2024 Nobel Laureate David Baker, is the first to commercialize protein products developed entirely through computational design as they don't occur naturally.See details»
Monod Bio 2025 Company Profile: Valuation, Funding …
Monod Bio General Information Description. Developer of biosensors designed to detect proteins, toxins, antibodies and other molecules. The company's …See details»
Monod Bio Inc. - life-sciences-usa.com
Nov 1, 2021 Monod Bio is a pioneer company in the design of custom de novo protein-based biosensors that emit light when they recognize its target. Monod Bio's innovative biosensor …See details»
Monod Bio, a David Baker lab spinout, gets $25 million for …
Aug 19, 2022 Monod Bio, a diagnostic biosensor company spun out of David Baker’s lab at the University of Washington Institute for Protein Design, has raised $25 million in seed funding.See details»
Monod Bio - Funding, Financials, Valuation & Investors - Crunchbase
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. ... How much …See details»
Monod Bio - Leadership Team - The Org
The Leadership Team at Monod Bio is responsible for steering the strategic direction of the company, making critical decisions to advance its biosensor technology, and ensuring …See details»
Monod Bio - VentureRadar
Monod Bio is a spin out from the University of Washington’s Institute for Protein Design. The company is developing biosensors that can quickly detect viral proteins, toxins, antibodies, or …See details»
Monod Bio - Contacts, Employees, Board Members, Advisors
Monod Bio is a life sciences company developing biosensors for protein and other analyte detection. New. Resources. Advanced Search. Start Free Trial . Talk With Sales. Pricing. Log …See details»
Monod Bio Company Profile - Office Locations, Competitors
Monod Bio is a life sciences company developing a biosensor platform. It uses computational protein engineering to create modular biosensing nanoswitches for analytical assays. The …See details»
Biosensor startup Monod lands $6M and spins out of Univ. of
Dec 23, 2021 Other Monod co-founders include IPD head Baker, IPD scientist Andy (Hsien Wei) Yeh and Dave Johnson, former CEO of VelosBio, which was acquired by Merck for $2.75 …See details»
Monod Bio Closes $25M Seed Financing to Advance Biosensor …
Aug 15, 2022 Monod Bio’s work illustrates the power of de novo protein design to create molecular devices from scratch with new and useful functions,” said David Baker, Ph.D., the …See details»
Monod Bio Raises $25M To Quickly Diagnose Diseases
Monod Bio Raises $25M To Quickly Diagnose Diseases. August 15, 2022 – 1 min read. Share this post: Much of disease detection goes like this: A physician directs a patient to get their …See details»
GHIC Invests in Monod Bio's Seed Financing
Aug 15, 2022 Monod Bio’s work illustrates the power of de novo protein design to create molecular devices from scratch with new and useful functions,” said David Baker, Ph.D., the …See details»
Monod Bio gets $25M for biosensors | C&EN Global Enterprise
Aug 22, 2022 Monod Bio, a diagnostic biosensor company spun out of David Baker’s lab at the University of Washington Institute for Protein Design, has raised $25 million in seed funding. …See details»
Biosensor startup Monod secures $25M seed financing
Aug 15, 2022 Monod Bio, a life sciences company developing custom diagnostic biosensors that emit light to detect specific biomolecules of interest, today announced it has raised a $25M …See details»
NovoBody - Monod Bio
NovoBody™ Binders: Next Generation Antibodies Antibodies have been the cornerstone of assay development for decades. Our NovoBody™ technology leverages state-of-the-art protein …See details»
Monod Bio - workinbiotech.com
Monod Bio is a young Seattle-based company developing custom de novo protein-based biosensors. They use a proprietary platform called LucCage, which combines engineering, …See details»